Jean Fraisse, MD | Authors



Impact of UFT on Tumoral TS and DPD Levels in Colorectal Cancer

October 01, 2000

This was an open lable, pilot translational clinical pharmacology study of a brief (7 day) course of UFT, 300 mg/m²/day, in combination with leucovorin, 90 mg/day, in six patients with newly diagnosed advanced colorectal cancer.